抑郁与抗抑郁药物均与骨折风险增加相关
本系列Meta分析显示抑郁和抗抑郁药物使用独立地与骨折风险增加相关,但不应忽视抗抑郁药对骨折的额外贡献及其作用。抑郁与抗抑郁药影响骨折风险的潜在机制可能不同。作者同意促进体力活动和心理治疗对防治轻度抑郁重要,但药物是否需要及选择何种药物应在临床中个体化决定,需考虑不同不良反应、药物对骨折风险的不同影响、抑郁严重程度及非药物治疗效果。
要点
- 抑郁和抗抑郁药物使用均独立地与骨折风险增加相关。
- 抑郁与抗抑郁药影响骨折风险的潜在机制可能不同。
- 药物是否需要及选择何种药物应在临床中个体化决定。
核心结论
- 系列Meta分析显示抑郁和抗抑郁药物使用独立地与骨折风险增加相关,但不应忽视抗抑郁药对骨折的额外贡献及其作用。
研究设计与样本
- 系列Meta分析。
主要发现
- 抑郁和抗抑郁药物使用独立地与骨折风险增加相关。
- 抑郁与抗抑郁药影响骨折风险的潜在机制可能不同。
临床怎么用
- 作者同意促进体力活动和锻炼以及有效的心理治疗对预防和治疗轻度抑郁很重要。
- 作者认为确定是否需要药物治疗以及为个体患者处方何种药物应在临床中基于个案决定。
- 作者认为临床中应考虑不同不良反应、不同抗抑郁药物对骨折风险的不同影响、抑郁严重程度以及非药物治疗的效果,以决定是否需要药物治疗及如何治疗个体患者。
局限性
- 原文未报告局限性
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Our series of meta-analyses showed that depression and antidepressant use are linked independently to an increased risk of fracture. However, in our meta-analysis research we never dismiss the possible of additional contributions of antidepressants to fractures, nor underestimate the role antidepressants play in the risk of fractures. Existing data indicates that the underlying mechanisms of the impact of depression and antidepressant on fracture risk are likely to be different. We agreed with Dr. Donzelli and his colleagues that promotion of physical activity and exercise, as well as effective psychotherapeutic intervention, is important to prevent and treat mild depression. However, determining if pharmacological therapies are needed, and which medication(s) should be prescribed for individual patients, should be done in clinic, on a case-by-case basis. Different adverse effects, varied impact on risk of fracture by antidepressant medication, severity of depression, and effectiveness of non-medication treatments should all be considered in clinical situations, in order to determine if pharmacological therapies are needed and how to treat individual patients.
引用
- Wu Q. Depression and antidepressant medications: both are linked to increased fracture risk. Osteoporos Int. 2018. PMID: 30488276. doi:10.1007/s00198-018-4785-1
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。